Intas Pharmaceuticals Ltd. Announces Licensing Agreement with mAbxience for Etanercept Biosimilar Targeting Autoimmune Diseases

Dec 20, 2023

Ahmedabad (Gujarat) [India], December 20: Intas Pharmaceuticals Ltd., a leading multinational pharmaceutical company, has announced today a strategic exclusive licensing agreement with mAbxience (a...

Prestige Biopharma's Herceptin Biosimilar Tuznue® Receives Positive CHMP Opinion from the EMA

Aug 01, 2024

Singapore, August 1: Prestige Biopharma, a pioneer in biopharmaceuticals, announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines...

Biocon Biologics partners with IDF to promote diabetes care

Feb 16, 2021

Bengaluru (Karnataka) [India], February 16 : Biocon Biologics has partnered with the International Diabetes Federation (IDF) as the first biosimilar insulin company to promote...

EMA approves Biocon Biologics' new monoclonal antibodies facility, renews GMP certifications for India and Malaysia sites

Jun 24, 2024

According to a press release, this facility, designed to produce multiple drug substances, will now commence the production of biosimilar Bevacizumab, enhancing the company's...

Biocon posts Rs 257 crore profit for Q4 on strong biosimilar business

Apr 29, 2021

Bengaluru (Karnataka) [India], April 29 : Biopharmaceuticals major Biocon Ltd on Thursday reported net profit of Rs 257 crore in the fourth quarter of...

Enzene Biosciences Ltd. obtains a Marketing Authorization for its Denosumab Biosimilar drug in India

Aug 27, 2021

Pune (Maharashtra) [India], August 27 (ANI/PRNewswire): Enzene Biosciences Ltd. "Enzene" announces a successful Marketing Authorization (MA) from the Drug Controller General of India (DCGI)...